NCT07029776 2026-03-03MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple MyelomaUniversity of ArkansasPhase 2 Not yet recruiting50 enrolled
NCT07407140 2026-03-02VAG-3+7-GInstitute of Hematology & Blood Diseases Hospital, ChinaPhase 3 Not yet recruiting300 enrolled